2024

1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

   Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

2. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

   Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

3. Chronic thromboembolic pulmonary hypertension treatment and sex: Systematic review and meta-analysis

   Medicina Clinica, Vol. 163, Núm. 6, pp. 269-274

4. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

   Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

5. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

6. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865

7. Duration of anticoagulation of venous thromboembolism

   Presse Medicale

8. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

   Thrombosis Research, Vol. 235, pp. 22-31

9. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

10. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

11. Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence

    Hamostaseologie, Vol. 44, Núm. 3, pp. 182-192

12. International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence

    Journal of the American College of Cardiology, Vol. 84, Núm. 16, pp. 1561-1577

13. Obesity a Prognostic Marker in Intermediate-high risk Pulmonary Embolism (PE)? RIETE Registry Review

    Thrombosis Update

14. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

15. Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses

    European Journal of Internal Medicine

16. Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study

    Thrombosis Research

17. Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: What is the best strategy for clinicians?

    Current Opinion in Pulmonary Medicine

18. Pulmonary embolism: Put the sPESI into practice

    European Journal of Internal Medicine

19. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

20. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73